Vigene Biosciences Is Now Part of Charles River

In June 2021, Charles River acquired Vigene Biosciences, a trusted leader in contract development and manufacturing (CDMO) solutions for cell and gene therapy. Vigene’s website has been completely integrated into Charles River’s website. We have since supported the development of 15 FDA-approved cell and gene therapies and have conducted more than 1,000 studies in this field over the past year.

Connect With Us

Explore Our Cell and Gene Therapy CDMO Solutions

Plasmid DNA Manufacturing

Viral Vector Manufacturing

Cell Therapy Manufacturing

Off-the-Shelf Plasmid Products

Viral Vector Packaging

Gene Therapy Manufacturing

Photo of the exterior of the Alderley Park, UK Cell and Gene Therapy CDMO Facility

Cell and Gene Therapy CDMO Facilities

Accelerate the development of your product and ensure it meets the highest regulatory standards while maintaining efficient production timelines through our integrated global network of contract development and manufacturing organization (CDMO) facilities and testing sites.

Explore our Sites

Still have questions for our cell and gene therapy specialists?
Connect With Us